Stage III Hepatocellular Carcinoma AJCC V8

general

Stage IIIA includes: T3, N0, M0. T3: Multiple tumors, at least one of which is larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)

46

Centers

69

Active Trials

$2.9B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Stage III Hepatocellular Carcinoma AJCC V8(46)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
High-Volume Research Center
71.0
4
NCI Comprehensive
Active Research Program
66.0
5
NCI Comprehensive
Active Research Program
66.0
6
NCI Comprehensive
Active Research Program
66.0
7
NCI Comprehensive
Active Research Program
66.0
8
NCI Comprehensive
Active Research Program
66.0
9
Active Research Program
66.0
10
Active Research Program
66.0
11
Active Research Program
66.0
12
NCI Comprehensive
Active Research Program
46.3
13
NCI Comprehensive
Active Research Program
46.3
14
NCI Comprehensive
Active Research Program
46.3
15
NCI Comprehensive
Active Research Program
46.3
16
NCI Comprehensive
Active Research Program
46.3
17
NCI Comprehensive
Active Research Program
46.3
18
NCI Comprehensive
Active Research Program
46.3
19
NCI Comprehensive
Active Research Program
46.3
20
NCI Comprehensive
Active Research Program
46.3
21
NCI Comprehensive
Active Research Program
46.3
2246.3
23
NCI Comprehensive
Active Research Program
46.3
24
NCI Comprehensive
Active Research Program
46.3
25
NCI Comprehensive
Active Research Program
46.3
26
NCI Comprehensive
Active Research Program
46.3
27
NCI Comprehensive
Active Research Program
46.3
28
NCI Clinical
Active Research Program
46.3
29
Active Research Program
46.3
30
NCI Clinical
Active Research Program
46.3
31
NCI Comprehensive
Active Research Program
46.3
32
NCI Comprehensive
Active Research Program
46.3
33
NCI Clinical
Active Research Program
46.3
34
Active Research Program
46.3
35
NCI Comprehensive
Active Research Program
46.3
36
Active Research Program
46.3
37
Active Research Program
46.3
38
Active Research Program
46.3
39
Active Research Program
46.3
40
NCI Comprehensive
29.8
41
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
29.8
42
NCI Comprehensive
43
NCI Comprehensive
44
NCI Comprehensive
45
NCI Comprehensive
46

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →